Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels

Fertility and Sterility

Volumn 94, Issue 3, 2010, Pages 905-912

  Bukulmez, Orhan ^a   Li, Qin ^a   Carr, Bruce R ^b   Leader, Benjamin ^c   Doody, Kathleen M ^d   Doody, Kevin J ^b,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c ReproSource   (United States)

^d Center for Assisted Reproduction   (United States)

Author keywords

AMH; anti mullerian hormone; oocyte donation; ovarian aging

Indexed keywords

ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; AGING; ARTICLE; BLOOD SAMPLING; CELL COUNT; COHORT ANALYSIS; EMBRYO; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; OOCYTE; OOCYTE DONATION; OVARIAN RESERVE; OVARY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CELL COUNT; DOWN-REGULATION; FEMALE; FERTILIZATION IN VITRO; HUMANS; OOCYTE DONATION; OOCYTES; OVULATION INDUCTION; PERIODICITY; PREGNANCY; PREGNANCY RATE; PREGNANCY TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955566356     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.05.017     Document Type: Article

References (38)

1. B. Vigier, J.Y. Picard, D. Tran, L. Legeai, and N. Josso Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells Endocrinology 114 1984 1315 1320
2. E.R. te Velde, and P.L. Pearson The variability of female reproductive ageing Hum Reprod Update 8 2002 141 154
3. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil Steril 77 2002 468 471
4. D.B. Seifer, and D.T. Maclaughlin Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance Fertil Steril 88 2007 539 546
5. I. Streuli, T. Fraisse, C. Pillet, V. Ibecheole, P. Bischof, and D. de Ziegler Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Fertil Steril 90 2008 395 400
6. D.S. Wachs, M.S. Coffler, P.J. Malcom, and R.J. Chang Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women J Clin Endocrinol Metab 92 2007 1871 1874
7. C. Caligara, J. Navarro, G. Vargas, C. Simon, A. Pellicer, and J. Remohi The effect of repeated controlled ovarian stimulation in donors Hum Reprod 16 2001 2320 2323 (Pubitemid 33054130)
8. O. Bukulmez, B.R. Carr, K.M. Doody, and K.J. Doody Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction Fertil Steril 89 2008 74 83
9. O. Bukulmez, K.S. Rehman, M. Langley, B.R. Carr, A.C. Nackley, and K.M. Doody Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation Reprod Biomed Online 13 2006 465 475
10. American Society for Reproductive Medicine Repetitive oocyte donation Fertil Steril 90 2008 S194 S195
11. M. Al-Azemi, A.L. Bernal, J. Steele, I. Gramsbergen, D. Barlow, and S. Kennedy Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis Hum Reprod 15 2000 72 75
12. A. Donner, and S. Bull Inferences concerning a common intraclass correlation coefficient Biometrics 39 1983 771 775
13. K.P. Tremellen, M. Kolo, A. Gilmore, and D.N. Lekamge Anti-mullerian hormone as a marker of ovarian reserve Aust N Z J Obstet Gynaecol 45 2005 20 24
14. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimullerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362
15. I.A. van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, and F.H. de Jong Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fertil Steril 83 2005 979 987
16. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
17. K. Oktay, D. Briggs, and R.G. Gosden Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles J Clin Endocrinol Metab 82 1997 3748 3751
18. S.J. Richardson, and J.F. Nelson Follicular depletion during the menopausal transition Ann N Y Acad Sci 592 1990 13 20 discussion 44-51
19. K.J. McTavish, M. Jimenez, K.A. Walters, J. Spaliviero, N.P. Groome, and A.P. Themmen Rising follicle-stimulating hormone levels with age accelerate female reproductive failure Endocrinology 148 2007 4432 4439
20. B. Gobert, P. Barbarino-Monnier, F. Guillet-May, M.C. Bene, and G.C. Faure Anti-ovary antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation J Reprod Fertil 96 1992 213 218
21. J. Serna, and J.A. Garcia-Velasco Effect of repeated assisted reproduction techniques on the ovarian response Curr Opin Obstet Gynecol 17 2005 233 236
22. A.P. Themmen Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker J Natl Cancer Inst Monogr 2005 18 21
23. R.D. van Beek, M.M. van den Heuvel-Eibrink, J.S. Laven, F.H. de Jong, A.P. Themmen, and F.G. Hakvoort-Cammel Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood J Clin Endocrinol Metab 92 2007 3869 3874
24. W.J. Hehenkamp, N.A. Volkers, F.J. Broekmans, F.H. de Jong, A.P. Themmen, and E. Birnie Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy Hum Reprod 22 2007 1996 2005
25. S.Y. Shin, J.R. Lee, G.W. Noh, H.J. Kim, W.J. Kang, and S.H. Kim Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status J Korean Med Sci 23 2008 104 110
26. J. van Disseldorp, M.J. Faddy, A.P. Themmen, F.H. de Jong, P.H. Peeters, and Y.T. van der Schouw Relationship of serum anti-Mullerian hormone concentration to age of menopause J Clin Endocrinol Metab 93 2008 2129 2134
27. A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, and S. Xella Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Hum Reprod 22 2007 766 771
28. S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, C. Gervy, and Y. Englert Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum Reprod 22 2007 1837 1840
29. S. Muttukrishna, H. McGarrigle, R. Wakim, I. Khadum, D.M. Ranieri, and P. Serhal Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112 2005 1384 1390
30. M. McIlveen, J.D. Skull, and W.L. Ledger Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population Hum Reprod 22 2007 778 785
31. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
32. J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, and R. Casamitjana Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment Hum Reprod 20 2005 915 922
33. I.A. van Rooij, F.J. Broekmans, C.C. Hunault, G.J. Scheffer, M.J. Eijkemans, and F.H. de Jong Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility Reprod Biomed Online 12 2006 182 190
34. T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, and D.B. Seifer Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Hum Reprod 21 2006 159 163
35. R. Fanchin, J. Taieb, D.H. Lozano, B. Ducot, R. Frydman, and J. Bouyer High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status Hum Reprod 20 2005 923 927
36. I. Streuli, T. Fraisse, C. Chapron, G. Bijaoui, P. Bischof, and D. de Ziegler Clinical uses of anti-Mullerian hormone assays: pitfalls and promises Fertil Steril 91 2009 226 230
37. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. Te Velde, and F.J. Broekmans Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
38. R. Fanchin, D.H. Mendez Lozano, N. Frydman, A. Gougeon, N. di Clemente, and R. Frydman Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization J Clin Endocrinol Metab 92 2007 1796 1802